The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Chronic Cavitary and Fibrosing Pulmonary and Pleural Aspergillosis: Case Series, Proposed Nomenclature Change, and Review
Abstract
We describe 18 nonimmunocompromised patients with chronic pulmonary aspergillosis. Duration of the disease ranged from several months to >12 years. All 18 patients had prior pulmonary disease. Weight loss, chronic cough (often with hemoptysis and shortness of breath), fatigue, and chest pain were the most common symptoms. All 18 patients had cavities, usually multiple and in 1 or both upper lobes of the lung, that expanded over time, with or without intraluminal fungal balls. All had detectable Aspergillus precipitins and inflammatory markers. Elevated levels of total immunoglobulin E were seen in 78% of patients and of Aspergillus-specific immunoglobulin E in 64%. Directed lung biopsies showed chronic inflammation, necrosis, or granulomas without hyphal invasion. Antifungal therapy with itraconazole resulted in 71% of patients improved or stabilized, with relapse common. Interferon-gamma treatment was useful in 3 patients. In azole nonresponders, modest responses to intravenous amphotericin B (80%) followed by itraconazole were seen. Surgery removed disease but postoperative pleural aspergillosis was inevitable. Indicators of good long-term medical outcomes were mild symptoms, thin-walled quiescent cavities, residual pleural fibrosis, and normal inflammatory markers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
Denning, D. W., & Stevens, D. A. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.6.1147 · Cited by 899
Self-citationHost-Pathogen Interactions: Redefining the Basic Concepts of Virulence and Pathogenicity
Casadevall, A., & Pirofski, L.-A. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3703-3713.1999 · Cited by 769
Pulmonary Aspergillosis in the Acquired Immunodeficiency Syndrome
Denning, D. W., Follansbee, S. E., Scolaro, M., Norris, S., Edelstein, H., & Stevens, D. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241003 · Cited by 503
Self-citationChronic Necrotizing Pulmonary Aspergillosis: A Discrete Clinical Entity
BINDER, R. E., FALING, L. J., PUGATCH, R. D., MAHASAEN, C., & SNIDER, G. L. (1982) · Medicine · doi:10.1097/00005792-198203000-00005 · Cited by 391
Daly, R. C., Pairolero, P. C., Piehler, J. M., Trastek, V. F., Payne, W. S., & Bernatz, P. E. (1986) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)35813-1 · Cited by 290
Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment.
Jewkes, J., Kay, P. H., Paneth, M., & Citron, K. M. (1983) · Thorax · doi:10.1136/thx.38.8.572 · Cited by 275
Gefter, W. B., Weingrad, T. R., Epstein, D. M., Ochs, R. H., & Miller, W. T. (1981) · Radiology · doi:10.1148/radiology.140.2.7255704 · Cited by 267
Aspergillus nidulans Infection in Chronic Granulomatous Disease
Segal, B. H., DeCarlo, E. S., Kwon-Chung, K. J., Malech, H. L., Gallin, J. I., & Holland, S. M. (1998) · Medicine · doi:10.1097/00005792-199809000-00004 · Cited by 263
Th1 and Th2 cytokines in mice with invasive aspergillosis
Cenci, E., Perito, S., Enssle, K. H., Mosci, P., Latgé, J. P., Romani, L., & Bistoni, F. (1997) · Infection and Immunity · doi:10.1128/iai.65.2.564-570.1997 · Cited by 217
Cenci, E., Mencacci, A., Del Sero, G., Bacci, A., Montagnoli, C., d'Ostiani, C. F., Mosci, P., Bachmann, M., Bistoni, F., Kopf, M., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315142 · Cited by 205
Madan, T., Kishore, U., Singh, M., Strong, P., Clark, H., Hussain, E. M., Reid, K. B. M., & Sarma, P. U. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10124 · Cited by 198
The course and prognosis of histoplasmosis
Rubin, H., Furcolow, M. L., Yates, J. L., & Brasher, C. A. (1959) · The American Journal of Medicine · doi:10.1016/0002-9343(59)90347-x · Cited by 159
Crosdale, D. J., Poulton, K., Ollier, W., Thomson, W., & Denning, D. W. (2001) · The Journal of Infectious Diseases · doi:10.1086/322791 · Cited by 148
Self-citationChronic forms of pulmonary aspergillosis
Denning, D. W. (2001) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2001.tb00006.x · Cited by 147
Self-citationCorticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.
Palmer, L. B., Greenberg, H. E., & Schiff, M. J. (1991) · Thorax · doi:10.1136/thx.46.1.15 · Cited by 146
[Chronic necrotizing pulmonary aspergillosis].
Wierzbicka, M. (1999) · PubMed · Cited by 130
Rello, J., Esandi, M., Mariscal, D., Gallego, M., Domingo, C., & Vallés, J. (1998) · Clinical Infectious Diseases · doi:10.1086/517672 · Cited by 118
Surgical treatment for pulmonary aspergilloma: a 28 year experience
Chen, J. C., Chang, Y., Luh, S.-P., Lee, J., & Lee, Y. C. (1997) · Thorax · doi:10.1136/thx.52.9.810 · Cited by 114
Clemons, K. V., Grünig, G., Sobel, R. A., Mirels, L. F., Rennick, D. M., & Stevens, D. A. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01382.x · Cited by 112
Protective Role of Lung Surfactant Protein D in a Murine Model of Invasive Pulmonary Aspergillosis
Madan, T., Kishore, U., Singh, M., Strong, P., Hussain, E. M., Reid, K. B. M., & Sarma, P. U. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2728-2731.2001 · Cited by 108
The histological spectrum of chronic necrotizing forms of pulmonary aspergillosis
Yousem, S. A. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90173-8 · Cited by 103
Israel, H. L., & Ostrow, A. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90150-8 · Cited by 96
Nonresolving pneumonia in steroid-treated patients with obstructive lung disease
Rodrigues, J. C., Niederman, M. S., Fein, A. M., et al. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90676-3 · Cited by 82
Surgical Management of Symptomatic Pulmonary Aspergilloma
Battaglini, J. W., Murray, G. F., Keagy, B. A., et al. (1985) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)61986-8 · Cited by 77
Chronic Necrotizing Pulmonary Aspergillosis: Pathologic Outcome After Itraconazole Therapy
Caras, W. E., & Pluss, J. L. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.1.25 · Cited by 73
Pittet, D., Huguenin, T., Dharan, S., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.2.8756836 · Cited by 70
A Long Term Study of 300 Patients With Cavitary-Abscess Lesions of the Lung of Coccidioidal Origin
Winn, W. A. (1968) · Diseases of the Chest · doi:10.1378/chest.54.supplement_1.268 · Cited by 49
Louie, A., Baltch, A. L., Franke, M. A., Smith, R. P., & Gordon, M. A. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.6.975 · Cited by 48
Hafeez, I. (2000) · Thorax · doi:10.1136/thorax.55.8.717 · Cited by 44
Rogers, P. D., Stiles, J. K., Chapman, S. W., & Cleary, J. D. (2000) · The Journal of Infectious Diseases · doi:10.1086/315835 · Cited by 40
The effects of itraconazole on the immune responses in ICR mice.
Joung Hoon, K. I. M., & Ahn, Y. K. (1994) · The Journal of Toxicological Sciences · doi:10.2131/jts.19.7 · Cited by 11
Cited by
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Self-citationPatterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citationAspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
Denning, D. W., Cadranel, J., Beigelman-Aubry, C., Ader, F., Chakrabarti, A., Blot, S., Ullmann, A. J., Dimopoulos, G., & Lange, C. (2016) · European Respiratory Journal · doi:10.1183/13993003.00583-2015 · Cited by 1,030
Self-citation
Metadata
- Authors
- Denning, D. W., Riniotis, K., Dobrashian, R., & Sambatakou, H.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10
- Volume
- 37
- Issue
- s3
- Pages
- S265-S280
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2152615086
- Cited by
- 554
- References
- 32
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.